Company presentation scheduled on Tuesday, March 4th at 9:10am ET –– EyePoint to provide enrollment update for ongoing DURAVYU™ Phase 3 pivotal ...

The webcast may also be accessed through Spero Therapeutics’ website (www.sperotherapeutics.com) on the “Events and Presentations” page under the “Connect” tab. A replay will be available on the ...

About Foghorn Therapeutics Foghorn ® Therapeutics is discovering and developing a novel class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Through ...

CAMBRIDGE, MA / ACCESS Newswire / February 25, 2025 / Moderna, Inc. , today announced its participation in the following upcoming investor conferences:TD Cowen 45th Annual Health Care Conference, on ...

Alterome Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering the development of next-generation, small molecule targeted therapies for the treatment of cancer, today announced ...

Aktis Oncology, an oncology company focused on unlocking the breakthrough potential of targeted radiopharmaceuticals for ...

Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today ...

Detailed price information for Monte Rosa Therapeutics Inc (GLUE-Q) from The Globe and Mail including charting and trades.

Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As ...

Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated ...

The Company was founded in response to the significant unmet need and lack of innovation in the mental health treatment ...

Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to ...